CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $9,000 | +50.0% | 325 | 0.0% | 0.00% | – |
| Q4 2014 | $6,000 | +50.0% | 325 | 0.0% | 0.00% | – |
| Q3 2014 | $4,000 | -20.0% | 325 | 0.0% | 0.00% | – |
| Q2 2014 | $5,000 | -16.7% | 325 | 0.0% | 0.00% | – |
| Q1 2014 | $6,000 | +200.0% | 325 | +225.0% | 0.00% | – |
| Q4 2013 | $2,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q3 2013 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |